Article

A Multidisciplinary Perspective on Research Participation in the Era of Post-Amyloid Disclosure and Disease-Modifying Therapies

2026-06-17

Abstract excerpt

<p>The emergence of disease-modifying therapies for Alzheimer's Disease (AD) and advances in plasma biomarker diagnostics for AD have transformed the landscape of research participation. Older adults are increasingly learning of elevated amyloid-beta (Aβ) through primary care, clinical trials or research involvement. This can occur years before the onset of cognitive symptoms. Motivations for involvement and expec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 51a7932b-af36-5a19-82fd-d1da500f84c4
DOI: 10.31234/osf.io/65snw_v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Multidisciplinary Perspective on Research Participation in the Era of Post-Amyloid Disclosure and Disease-Modifying TherapiesDOI 10.31234/osf.io/65snw_v1Read

Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease ContinuumSemantic proximity Read

More Than Results: A Qualitative Study on the Role of Person-Centered Genetic Counseling in Parkinson’s Disease ResearchSemantic proximity Read

Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.Semantic proximity Read

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research contextSemantic proximity Read

Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of viewSemantic proximity Read

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.Semantic proximity Read

‘That would be dreadful’: The ethical, legal, and social challenges of sharing your Alzheimer’s disease biomarker and genetic testing results with othersSemantic proximity Read

Research participants' perspectives on genotype-driven research recruitment.Semantic proximity Read

Patient and Public Involvement to Co-Design How We Understand and Communicate Mortality Risk for Patients Aged 90 and Over Considering Elective Total Hip Replacement (THR)Semantic proximity Read

"It seems enormously valuable to me." Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing.Semantic proximity Read

Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic reviewSemantic proximity Read

Participant attitudes toward returning individual results from CADASIL researchSemantic proximity Read